![]() |
||||||||||||||||
![]() |
||||||||||||||||
|
||||||||||||||||
Dr. Ronen Y. Durst, MD
Assistant Professor
Harvard Medical School
Massachusetts General Hospital
Cardiac Echo Lab, Blake 2 - Room 255
55 Fruit St
Boston, MA 02114
Phone: (617) 726-0832
Fax: (617) 726-8383
rdurst@partners.org
MEET OUR TEAM
INVESTIGATORS:
Dr. Simon Body
Dr. Ronen Durst
Dr. Robert Levine
Dr. Christine Seidman
Dr. Jon Seidman
Dr. Stan Shernan
Dr. Susan Slaugenhaupt
STAFF:
Dr. Kujtim Bodinaku
Ms. Svetlana Gorbatov
Mr. James Gosnell
Ms. Adrienne Kicza
Ms. Barbara McDonough
Ms. Leah Rastiello
Ms. Elizabeth Sparks
Education / Training
Medical School: Hebrew University - Hadassah Medical School, Jerusalem, Israel
Residencies / Fellowships: Hadassah Medical Center, Jerusalem, Israel, and Massachusetts General Hospital (Cardio Imaging)
Research focus:
Representative Publications:
Durst R, Neumark Y, Meiner V, Friedlander Y, Sharon N, Polak A, Mosseri M, Beeri R, Danenberg H, Pugatch T, Erez G, Spitzen S, Ben-Avi L, Leitersdorf E, Lotan C. Increased risk for atherosclerosis of various macrophage scavenger receptor 1 alleles. Genet Test Mol Biomarkers. 2009;13:583-7.
Friedlander Y, Schwartz SM, Durst R, Meiner V, Robertson AS, Erez G, Leitersdorf E, Siscovick DS. SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction. Atherosclerosis. 2008,196:896-904.
Durst R, Lotan C, Nassar H, Gotsman M, Mor E, Varshitzki B, Greganski P, Jabara R, Admon D, Meerkin D, Mosseri M. Comparison of 4 and 6 French catheters for coronary angiography: real-world modeling. Isr Med Assoc J. 2007:290-3.
Durst R, Danenberg H, Gallily R, Beeri R, Mechoulam R, Meir K, Pugatsch T, Grad E, Tarsish E and Lotan C. Cannabidiol, a non-psychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury, Am J physiology. 2007,293:H3602-H3607.
Durst R, Jansen A, Erez G, Bravdo R, Butbul E, Ben Avi L, Shpitzen S, Lotan C, Leitersdorf E, Defesche J, Friedlander Y, Meiner V and Miserez A. R.. The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients. Atherosclerosis, 2006 ;189:443-50.
|